On the other hand, the availability of liver-selective TH analogs with a higheraffinity for the THR-β, the main THR isoform expressed in the liver, might be aninteresting treatment also for hypothyroid patients with NAFLD not responsive toL-T4 alone. Here, TH is linked to metabolic dysfunction-associated steatotic liver disease.